Team:UFMG Brazil/Talks
From 2013.igem.org
(Difference between revisions)
(→Talking to experts) |
(→Heart diseases in the Brazilian healthcare system (SUS)) |
||
(6 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
+ | {{Team:UFMG Brazil/barra}} | ||
+ | {{carlos_teste}} | ||
+ | {{Cardbio_barra_home_hp}} | ||
+ | {{Cardbio_barra_hp}} | ||
+ | |||
+ | <html> | ||
+ | <style> | ||
+ | |||
+ | #iconHP1{ | ||
+ | background-color:#F83939; | ||
+ | } | ||
+ | |||
+ | </style> | ||
+ | </html> | ||
+ | |||
=Talking to experts= | =Talking to experts= | ||
Line 6: | Line 21: | ||
Before starting any experimental procedure, our lab heroes were trained by Neusa Antunes, an expert on biosafety from our institute. More than how to proceed in the lab, we could debate about what is biosafety and other concepts regarding it, which role laws play, what iGEM teams and researchers must be aware of and ethical questions related do synthetic biology. | Before starting any experimental procedure, our lab heroes were trained by Neusa Antunes, an expert on biosafety from our institute. More than how to proceed in the lab, we could debate about what is biosafety and other concepts regarding it, which role laws play, what iGEM teams and researchers must be aware of and ethical questions related do synthetic biology. | ||
+ | |||
<html><center><object width="640" height="480"><param name="movie" value="//www.youtube.com/v/_vb1huQtiwk?hl=en_US&version=3"></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="//www.youtube.com/v/_vb1huQtiwk?hl=en_US&version=3" type="application/x-shockwave-flash" width="640" height="480" allowscriptaccess="always" allowfullscreen="true"></embed></object></center> </html> | <html><center><object width="640" height="480"><param name="movie" value="//www.youtube.com/v/_vb1huQtiwk?hl=en_US&version=3"></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="//www.youtube.com/v/_vb1huQtiwk?hl=en_US&version=3" type="application/x-shockwave-flash" width="640" height="480" allowscriptaccess="always" allowfullscreen="true"></embed></object></center> </html> | ||
+ | |||
+ | |||
+ | ==Heart diseases in the Brazilian healthcare system (SUS)== | ||
+ | |||
+ | We interviewed the director of the teaching hospital of the UFMG, Dr. Antonio Luiz Pinho Ribeiro (Tom), who is also a consultant in cardiology of the Brazilian Ministry of Health. Talking to him, we could know more about the SUS (Unified Health System), the care of cardiac patients, the importance of new biomarkers for early diagnosis and the risk stratification in cardiology, the structure of the hospital and more, providing us important information for the development of our project. Check it! | ||
+ | |||
+ | |||
+ | <html><center><object width="640" height="480"><param name="movie" value="//www.youtube.com/v/GbQtSbW4K5s?version=3&hl=en_US"></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="//www.youtube.com/v/GbQtSbW4K5s?version=3&hl=en_US" type="application/x-shockwave-flash" width="640" height="480" allowscriptaccess="always" allowfullscreen="true"></embed></object></center></html> | ||
+ | |||
+ | {{Team:UFMG Brazil/sponsor}} |
Latest revision as of 00:34, 29 October 2013